While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...
All the company’s insulin products will be capped for both insured and uninsured customers with prescriptions. Last February, Ellison announced a settlement with Eli Lilly capping prices at $35 ...
Two counties in the Charlotte area have filed lawsuits in the last few weeks over the price of insulin. Gaston County and ...
Eli Lilly bought a stake in Protomer Technologies ... Humulin – which launched in 1982 and remains on sale. Insulin products remain a multibillion-dollar business for the company, alongside ...
The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog ...
If California patients pay more than $35 per month for insulin now, it’s in large part because PBMs have rigged the system in ...
The announcement comes nearly a year after his office's settlement with Eli Lilly, which eventually slashed prices on its most prescribed insulin products by 70%, as well as capping out-of-pocket ...
The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...
Three major manufacturers, Eli Lilly, Novo Nordisk, and Sanofi, which together supply most insulin in the United States recently announced 70% to 75% price reductions on their insulin products.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback